Cargando…
Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
BACKGROUND: To identify pretreatment carcinoembryonic antigen (CEA) levels as a risk factor for para-aortic lymph node (PALN) recurrence following concurrent chemoradiotherapy (CCRT) for cervical cancer. METHODS: From March 1995 to January 2008, 188 patients with squamous cell carcinoma (SCC) of the...
Autores principales: | Huang, Eng-Yen, Huang, Yu-Jie, Chanchien, Chan-Chao, Lin, Hao, Wang, Chong-Jong, Sun, Li-Min, Tseng, Chin-Wen, Tsai, Ching-Chou, Ou, Yu-Che, Fu, Hung-Chun, Chen, Hui-Chun, Hsu, Hsuan-Chih, Wang, Chang-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298789/ https://www.ncbi.nlm.nih.gov/pubmed/22289572 http://dx.doi.org/10.1186/1748-717X-7-13 |
Ejemplares similares
-
Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.
por: Kenter, G., et al.
Publicado: (1987) -
Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma
por: Huang, Yi, et al.
Publicado: (2023) -
Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
por: Hu, Ke, et al.
Publicado: (2018) -
Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
por: Ho, Yu-Chieh, et al.
Publicado: (2023) -
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
por: Chen, Chih-Yi, et al.
Publicado: (2018)